GoodRx Holdings (GDRX) Operating Leases (2019 - 2025)
GoodRx Holdings (GDRX) has disclosed Operating Leases for 7 consecutive years, with $54.5 million as the latest value for Q4 2025.
- Quarterly Operating Leases rose 18.47% to $54.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.5 million through Dec 2025, up 18.47% year-over-year, with the annual reading at $54.5 million for FY2025, 18.47% up from the prior year.
- Operating Leases hit $54.5 million in Q4 2025 for GoodRx Holdings, up from $51.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $56.3 million in Q1 2023 to a low of $32.0 million in Q3 2021.
- Historically, Operating Leases has averaged $44.7 million across 5 years, with a median of $48.0 million in 2023.
- Biggest five-year swings in Operating Leases: skyrocketed 73.1% in 2023 and later decreased 12.75% in 2025.
- Year by year, Operating Leases stood at $33.6 million in 2021, then soared by 61.14% to $54.1 million in 2022, then decreased by 10.58% to $48.4 million in 2023, then decreased by 4.88% to $46.0 million in 2024, then rose by 18.47% to $54.5 million in 2025.
- Business Quant data shows Operating Leases for GDRX at $54.5 million in Q4 2025, $51.3 million in Q3 2025, and $52.7 million in Q2 2025.